Back

CANTOS - Modulation of the Interleukin-6 Signaling Pathway and Incidence Rates of Atherosclerotic Events and Mortality

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Clinical Trial Updates Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

11 More presentations in this session

Presentation thumbnail
COMPASS Trial - Bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban
Doctor J. Eikelboom (Hamilton, CA)
Slides Video
Presentation thumbnail
Discussant review - COMPASS.
Professor L. Wallentin (Uppsala, SE)
Slides Video
Presentation thumbnail
Discussant review - CANTOS.
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
CABANA Trial - Recurrence of Atrial Arrhythmias in the Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation
Professor J. Poole (Seattle, US)
Slides Video
Presentation thumbnail
Discussant review - CABANA.
Professor C. Leclercq (Rennes, FR)
Slides Video

Access the full session

Session thumbnail
Clinical Trial Updates

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources